SLS Bio (KOSDAQ:246250) will be delisted from South Korea's KOSDAQ market on Nov. 5, according to a Monday filing with the Korea Exchange.
The Korea Exchange finalized the delisting decision following a formal review assessing the company's business continuity, financial health, and management transparency.
Trading of the firm's 15.4 million common shares will resume for a liquidation trading period from Oct. 27 to Nov. 4, during which transactions will execute via 30-minute single-price competitive call auctions without daily price limits.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments